Overview
- Fidji Simo announced Thursday that she will leave her full-time post and become a part-time adviser after a three-month medical leave caused by a severe flare-up of a chronic neuroimmune condition she has lived with for seven years.
- OpenAI has not named a single successor and plans to split Simo’s product and business duties across senior leaders, with president Greg Brockman already covering product during her absence and reports naming CFO Sarah Friar and CSO Jason Kwon as other recipients of responsibilities.
- Simo said she will prioritize recovery while continuing to contribute on health-focused work through OpenAI and outside efforts such as ChronicleBio, and she reiterated her view that AI should be used to solve health problems.
- The announcement coincides with major product activity at OpenAI — including new flagship model updates and a push to consolidate products into a single agentic experience — and follows a wave of recent senior role changes at the company.
- The redistribution of duties during IPO preparations raises governance and investor questions about leadership continuity and who will ultimately hold a single No. 2 operational role as OpenAI scales its consumer and enterprise businesses.